These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 33866112)
41. FDG-avid presacral soft tissue mass in previously treated rectal cancer: Diagnostic outcome and additional value of MRI, including diffusion-weighted imaging. Pennings JP; de Haas RJ; Murshid KJA; de Jong KP; Dierckx RAJO; Kwee TC Eur J Surg Oncol; 2019 Apr; 45(4):606-612. PubMed ID: 30594404 [TBL] [Abstract][Full Text] [Related]
42. Post-treatment Jung AR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY Oral Oncol; 2020 Aug; 107():104750. PubMed ID: 32361565 [TBL] [Abstract][Full Text] [Related]
43. Value of [18F]FDG PET-CT in the follow-up of surgically treated oral tongue squamous cell carcinoma: single centre cohort analysis on 87 patients. Ravanelli M; Grammatica A; Squassina G; Bertagna F; Albano D; Lancini D; Bosio P; Zigliani A; Agazzi GM; Maroldi R; Nicolai P; Giubbini R; Piazza C; Farina D Nucl Med Rev Cent East Eur; 2021; 24(2):58-62. PubMed ID: 34382669 [TBL] [Abstract][Full Text] [Related]
44. Primary Tumor ¹⁸F-FDG Avidity Affects the Performance of ¹⁸F-FDG PET/CT for Detecting Gastric Cancer Recurrence. Kim SJ; Cho YS; Moon SH; Bae JM; Kim S; Choe YS; Kim BT; Lee KH J Nucl Med; 2016 Apr; 57(4):544-50. PubMed ID: 26678615 [TBL] [Abstract][Full Text] [Related]
45. PET-CT for Staging and Detection of Recurrence of Head and Neck Cancer. Wong WL Semin Nucl Med; 2021 Jan; 51(1):13-25. PubMed ID: 33246535 [TBL] [Abstract][Full Text] [Related]
47. Prognostic value of Lee JR; Almuhaimid TM; Roh JL; Oh JS; Kim SJ; Kim JS; Choi SH; Nam SY; Kim SY J Surg Oncol; 2018 Sep; 118(4):644-650. PubMed ID: 30132891 [TBL] [Abstract][Full Text] [Related]
48. Comparison of diffusion-weighted MR imaging and Schroeder C; Lee JH; Tetzner U; Seidel S; Kim SY Eur J Radiol; 2020 Sep; 130():109157. PubMed ID: 32652403 [TBL] [Abstract][Full Text] [Related]
49. Multiparametric functional MRI and Martens RM; Koopman T; Lavini C; Ali M; Peeters CFW; Noij DP; Zwezerijnen G; Marcus JT; Vergeer MR; Leemans CR; de Bree R; de Graaf P; Boellaard R; Castelijns JA Eur Radiol; 2021 Feb; 31(2):616-628. PubMed ID: 32851444 [TBL] [Abstract][Full Text] [Related]
58. Fluorodeoxyglucose-positron emission tomography scan-positive recurrent papillary thyroid cancer and the prognosis and implications for surgical management. Schreinemakers JM; Vriens MR; Munoz-Perez N; Guerrero MA; Suh I; Rinkes IH; Gosnell J; Shen WT; Clark OH; Duh QY World J Surg Oncol; 2012 Sep; 10():192. PubMed ID: 22985118 [TBL] [Abstract][Full Text] [Related]
59. Improvement in the detection of locoregional recurrence in head and neck malignancies: F-18 fluorodeoxyglucose-positron emission tomography/computed tomography compared to high-resolution contrast-enhanced computed tomography and endoscopic examination. Rangaswamy B; Fardanesh MR; Genden EM; Park EE; Fatterpekar G; Patel Z; Kim J; Som PM; Kostakoglu L Laryngoscope; 2013 Nov; 123(11):2664-9. PubMed ID: 23553147 [TBL] [Abstract][Full Text] [Related]
60. In situ pedicle lengthening and perforator shifting technique for overcoming the perforator variation of the anterolateral thigh free flap during head and neck reconstruction. Wu CY; Lai CS; Wang YP; Chen IC; Lu CT; Feng CH; Tsai YC Microsurgery; 2021 Nov; 41(8):743-752. PubMed ID: 34498755 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]